Journal of Assisted Reproduction and Genetics

, Volume 19, Issue 8, pp 384–389 | Cite as

Effect of In Vivo GnRH Agonist and GnRH Antagonist on hCG and Insulin-Stimulated Progesterone Production by Human Granulosa-Lutein Cells In Vitro

  • Mohamed F. M. Mitwally
  • Robert F. CasperEmail author


Purpose: To investigate hCG and insulin-stimulated progesterone (P) production by human granulosa-lutein cells (hGLC) in vitro.

Methods: hGLCs were isolated from patients undergoing IVF-ET cycles in which GnRH agonist or GnRH antagonist was used to prevent a midcycle gonadotropin surge. The cells were cultured for 3 days, and then treated with hCG 0.5, 1, and 10 IU/I, and insulin 0.01, 0.1, and 1 μM in serum free conditions. In vitro P production was measured by enzyme immunoassay.

Results: hCG stimulated P production by hGLCs from cycles in which GnRH antagonist was used, but a blunted response was seen in GnRH-agonist treated cycles. Insulin-stimulated P production was similar in cells from cycles in which GnRH-agonist or GnRH-antagonist treatment was used.

Conclusions: Because insulin and hCG may share common pathways beyond the level of receptor activation, we hypothesize that GnRH agonist, but not GnRH antagonist, may affect the expression and/or activation of LH receptors in the hGLCs.

GnRH agonist GnRH antagonist granulosa cells progesterone 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hughes EG, Fedorkow DM, Daya S, Sagle MA, van de Koppel P, Collins JA: The routine use of gonadotropinreleasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: A meta-analysis of randomized controlled trials. Fertil Steril 1992;58:888-896Google Scholar
  2. 2.
    Diedrich K, Diedrich C, Santos E, Bauer O, Zoll C, AI-Hasani S, Reissman T, Krebs D, Klingmuller D: Suppression of the endogenous luteinizing hormone surge by the gonadotrophinreleasing hormone antagonist cetrorelix during ovarian stimulation. Hum Reprod 1994;9:788-791Google Scholar
  3. 3.
    Minaretzis D, Alper MM, Oskowitz SP, Lobel SM, Mortola JF, Pavlonz SN: Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: Cycle performance and in vitro steroidogenesis of granulosa lutein cells. AmJ Obstet Gynecol 1995;172:1518-1525Google Scholar
  4. 4.
    Felberbaum RE, Reissmann T, KuÈ pker W, Bauer O, AI-Hasani S, Diedrich C, Diedrich K: Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility. Eur J Obstet Gynecol Reprod Biol 1995;61:151-155Google Scholar
  5. 5.
    Felberbaum R, Reissmann T, KuÈ pker W, AI-Hasani S, Bauer O, Schill T, Zoll C, Diedrich C, Diedrich K: Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist cetrorelix at different dosages. J Assist Reprod Genet 1996;13:216-222Google Scholar
  6. 6.
    Albano C, Smitz J, Camus M, RiethmuÈ ller-Winzen H, van Steirteghem A, Devroey P: Comparison of different doses of gonadotropin-releasing hormone antagonist cetrorelix during controlled ovarian hyperstimulation. Fertil Steril 1997;67: 917-922Google Scholar
  7. 7.
    Peng C, Fan NC, Ligier M, Vaananen J, Leung PC: Expression and regulation of gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acids in human granulosa-luteal cells. Endocrinology 1994;135:1740-1746Google Scholar
  8. 8.
    Minaretzis D, Jakubowski M, Mortola JF, Pavlon SN: Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosa lutein cells. J Clin Endocrinol Metab 1995;80:430-434Google Scholar
  9. 9.
    Tureck RW, Mastroianni L Jr, Blasco L, Strauss JF III: Inhibition of human granulosa cell progesterone secretion by a gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab 1982;54:1078-1080Google Scholar
  10. 10.
    Casper RF, Erickson GF, Rebar RW, Yen SS: The effect of luteinizing hormone-releasing factor and its agonist on cultured human granulosa cells. Fertil Steril 1982;37:406-409Google Scholar
  11. 11.
    Casper RF, Erickson GF, Yen SS: Studies on the effect of gonadotropin-releasing hormone and its agonist on human luteal steroidogenesis in vitro. Fertil Steril 1984;42: 39-43Google Scholar
  12. 12.
    Parinaud J, Beaur A, Bourreau E, Vicitez G, Pontonnier G: Effect of a luteinizing hormone-releasing hormone agonist (buserelin) on steroidogenesis of cultured human preovulatory granulosa cells. Fertil Steril 1988;50:597-602Google Scholar
  13. 13.
    Bussenot I, Azoulay Barjonet C, Parinaud J: Modulation of the steroidogenesis of cultured human granulosa lutein cells by gonadotropin-releasing hormone analogs. J Clin Endocrinol Metab 1993;76:1376-1379Google Scholar
  14. 14.
    Weiss JM, Oltmanns K, GuÈ rke EM, Polack S, Eick F, Felberbaum R, Diedrich K, Ortmann O: Actions of gonadotropin-releasing hormone antagonists on steroidogenesis in human granulosa lutein cells. Eur J Endocrinol 2001;144:677-685Google Scholar
  15. 15.
    Pellicer A, Miro F: Steroidogenesis in vitro of human granulosa-luteal cells pretreated in vivo with gonadotropinreleasing hormone analogs. Fertil Steril 1990;54:590-596Google Scholar
  16. 16.
    Lin Y, Kahn JA, Hillensjö T: Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist? Hum Reprod 1999;14:885-888Google Scholar
  17. 17.
    Frederick JL, Hickey MJ, Francis MM, Sauer MV, Paulson RJ: The effect of leuprolide acetate on steroidogenesis by granulose and theca cells in vitro. J In Vitro Fertil Embryo Transf 1991;8:230-234Google Scholar
  18. 18.
    Fabbri R, Porcu E, Pession E, Sereni E, Marsella T, Seracchioli R, Flamigni C: The effect of leuprorelin on steroidogenesis of human preovulatory granulosa cells in vitro. J Assist Reprod Genet 1996;13:287-292Google Scholar
  19. 19.
    Olsson JH, Akesson I, Hillensio T: Effects of a gonadotropinreleasing hormone agonist on progesterone formation in cultured human granulosa cells. Acta Endocrinologica 1990;122:427-431Google Scholar
  20. 20.
    Guerrero HE, Stein P, Asch RH, de Fried EP, Tesone M: Effect of a gonadotropin-releasing hormone agonist on luteinizing hormone receptors and steroidogenesis in ovarian cells. Fertil Steril 1993;59:803-808Google Scholar
  21. 21.
    Gaetje R: Influence of gonadotropin releasing hormone (GnRH) and a GnRH-agonist on granulosa cell steroidogensis. Clin Exp Obstet Gynecol 1994;21:164-169Google Scholar
  22. 22.
    Uemura T, Namiki T, Kimura A, Yanagisawa T, Minaguchi H: Direct effects of gonadotropin-releasing hormone on the ovary in rats and humans. Horm Res 1994;41:7-13Google Scholar
  23. 23.
    Pellicer A, Tarin JJ, Miro F, Sampaio M, Delos Santos MJ, Remohi J: The use of gonadotropin-releasing hormone analogues (GnRHa), in in vitro fertilization: Some clinical and experimental investigations of a direct effect on the human ovary. Hum Reprod 1992;7:39-47Google Scholar
  24. 24.
    Hamori M, Torok A, Zwirner M, Batteux C, Schinkmann W, Bodis J: In vitro progesterone production of human granulose luteal cells: The impact of different stimulation protocols, poor response and polycystic ovarian syndrome. Hum Reprod 1992;7:592-596Google Scholar
  25. 25.
    Dirnfeld M, Goldman S, Gonen Y, Koifman M, Lissak A, Kraiem Z, Abramovici H: Functional differentiation in progesterone secretion by granulosa versus cumulus cells in the human preovulatory follicle and the effect of different induction of ovulation protocols. Fertil Steril 1993;60:1025-1030Google Scholar
  26. 26.
    Brus L, Lambalk CB, de Koning J, Helder MN, Janssens RM, Schoemaker J: Specific gonadotrophin-releasing hormone analogue binding predominantly in human luteinized follicular aspirates and not in human preovulatory follicles. HumReprod 1997;12:769-773Google Scholar
  27. 27.
    Lin LS, Roberts VJ, Yen SS: Expression of human gonadotropin-releasing hormone receptor gene in the placenta and its functional relationship to human chorionic gonadotropin secretion. J Clin Endocrinol Metab 1995;80: 580-585Google Scholar
  28. 28.
    Spona J, Coy DH, Zatlasch E, Wakolbinger C: LH-RH antagonist inhibits gonadal steroid secretion in vitro. Peptides 1985;6:379-382Google Scholar
  29. 29.
    Ragni G, Vegetti W, Baroni E, Colombo M, Arnoldi M, Lombroso G, Crosignani PG: Comparison of luteal phase profile in gonadotrophin stimulated cycles with or without a gonadotrophin-releasing hormone antagonist. Hum Reprod 2001;16:2258-2262Google Scholar
  30. 30.
    Garcia-Velasco JA, Isaza V, Vidal C, Landazábal A, Remohí J, Simon C, Pellicer A: Human ovarian steroid secretion in vivo: Effects of GnRH agonist versus antagonist (cetrorelix). Hum Reprod 2001;16:2533-2539Google Scholar

Copyright information

© Plenum Publishing Corporation 2002

Authors and Affiliations

  1. 1.Division of Reproductive Sciences, Department of Obstetrics and GynecologySamuel Lunenfeld Research Institute and Mount Sinai Hospital, University of TorontoTorontoCanada
  2. 2.Department of Gynecology and ObstetricsState University of New York (SUNY) at BuffaloBuffalo

Personalised recommendations